Otsuka Holdings
4578.T
#746
Rank
HK$245.69 B
Marketcap
HK$465.22
Share price
0.13%
Change (1 day)
6.86%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: HK$8.18 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are HK$14.47 Billion. In 2023 the company made an earning of HK$8.18 Billion a decrease over its 2022 earnings that were of HK$10.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023HK$8.18 B-20.93%
2022HK$10.34 B-12.7%
2021HK$11.85 B-19.92%
2020HK$14.80 B13.9%
2019HK$12.99 B52.07%
2018HK$8.54 B11.22%
2017HK$7.68 B-36.03%
2016HK$12.01 B31.15%
2015HK$9.15 B
2013HK$19.01 B33.52%
2012HK$14.23 B-4.65%
2011HK$14.93 B45.53%
2010HK$10.26 B